| Autor: |
Boroujeni, Mahshid Badakhshan, Mohebi, Samane, Malekian, Azam, Shahraeini, Seyed Sadegh, Gharagheizi, Zahra, Shahkolahi, Shaghayegh, Sadeghi, Rezvaneh Vahedian, Naderifar, Mahin, Akbarizadeh, Majid Reza, Soltaninejad, Simin, Moghadam, Zahra Taati, Moghadam, Majid Taati, Mirzadeh, Farzane |
| Zdroj: |
Biotechnology & Bioengineering; Jan2024, Vol. 121 Issue 1, p82-99, 18p |
| Abstrakt: |
Defending against antibiotic‐resistant infections is similar to fighting a war with limited ammunition. As the new century unfolded, antibiotic resistance became a significant concern. In spite of the fact that phage treatment has been used as an effective means of fighting infections for more than a century, researchers have had to overcome many challenges of superbug bacteria by manipulating phages and producing engineered enzymes. New enzymes and phages with enhanced properties have a significant impact on the ability to fight antibiotic‐resistant infections, which is considered a window of hope for the future. This review, therefore, illustrates not only the challenges caused by antibiotic resistance and superbug bacteria but also the engineered enzymes and phages that are being developed to solve these issues. Our study found that engineered phages, phage proteins, and enzymes can be effective in treating superbug bacteria and destroying the biofilm caused by them. Combining these engineered compounds with other antimicrobial substances can increase their effectiveness against antibiotic‐resistant bacteria. Therefore, engineered phages, proteins, and enzymes can be used as a substitute for antibiotics or in combination with antibiotics to treat patients with superbug infections in the future. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text